Enanta Pharmaceuticals, Inc. (ENTA)
Company Info
Highlights
$152.31M
-$4.95
$66.59M
$65.97M
-$98.11M
$4.71 - $17.80
$15.43
16.76%
5.18
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Enanta Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Enanta Pharmaceuticals, Inc. had a return of 24.17% year-to-date (YTD) and -45.03% in the last 12 months. Over the past 10 years, Enanta Pharmaceuticals, Inc. had an annualized return of -14.96%, while the S&P 500 had an annualized return of 11.26%, indicating that Enanta Pharmaceuticals, Inc. did not perform as well as the benchmark.
ENTA
24.17%
36.00%
-43.47%
-45.03%
-33.22%
-14.96%
^GSPC (Benchmark)
3.96%
1.97%
9.03%
22.16%
12.60%
11.26%
Monthly Returns
The table below presents the monthly returns of ENTA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -11.13% | 24.17% | |||||||||||
| 2024 | 29.12% | 18.27% | 21.50% | -21.31% | -9.24% | 4.01% | 13.80% | -12.74% | -19.57% | 8.54% | -23.52% | -33.14% | -38.89% |
| 2023 | 14.75% | -9.14% | -16.62% | -12.09% | -33.95% | -8.86% | -11.36% | -21.72% | -24.78% | -19.25% | 3.55% | 0.75% | -79.77% |
| 2022 | -20.54% | 18.51% | 1.08% | -9.53% | -38.00% | 18.38% | 16.67% | 10.39% | -14.80% | -13.03% | -2.93% | 6.23% | -37.79% |
| 2021 | 14.16% | 2.62% | 0.00% | 2.88% | -4.10% | -9.56% | -4.00% | 35.38% | -0.68% | 51.12% | 2.83% | -15.29% | 77.62% |
| 2020 | -16.57% | -1.28% | 1.08% | -9.84% | 11.04% | -2.49% | -8.68% | 13.83% | -12.28% | -4.70% | -5.57% | 2.18% | -31.85% |
| 2019 | 12.14% | 29.09% | -6.85% | -8.72% | 3.76% | -6.73% | -11.09% | -5.96% | -14.84% | 1.33% | 4.57% | -2.95% | -12.78% |
| 2018 | 44.77% | -7.45% | 2.91% | 15.00% | 7.24% | 16.14% | -15.86% | -6.76% | -6.02% | -9.71% | 2.57% | -10.50% | 20.71% |
| 2017 | -1.12% | -13.00% | 6.87% | 3.08% | -5.26% | 19.61% | 5.92% | 12.46% | 9.19% | 6.13% | -0.02% | 18.16% | 75.16% |
| 2016 | -22.17% | 10.47% | 3.45% | -0.58% | -15.99% | -10.11% | 2.00% | -2.22% | 21.01% | -11.61% | 33.67% | 6.55% | 1.45% |
| 2015 | -14.57% | -17.54% | -14.52% | 11.82% | 19.39% | 10.05% | 12.58% | -22.92% | -7.43% | -22.27% | 12.14% | 4.83% | -35.06% |
| 2014 | 34.09% | 0.71% | 8.55% | -6.95% | 2.07% | 13.40% | -12.68% | 11.57% | -5.70% | 8.67% | 9.16% | 8.33% | 86.40% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ENTA is 17, meaning it’s performing worse than 83% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Enanta Pharmaceuticals, Inc. (ENTA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Enanta Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Enanta Pharmaceuticals, Inc. was 96.19%, occurring on Jan 15, 2025. The portfolio has not yet recovered.
The current Enanta Pharmaceuticals, Inc. drawdown is 94.35%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.19% | Jul 10, 2018 | 1640 | Jan 15, 2025 | — | — | — |
| -59.6% | Dec 30, 2014 | 398 | Jul 28, 2016 | 348 | Dec 13, 2017 | 746 |
| -28.47% | Dec 11, 2013 | 14 | Dec 31, 2013 | 23 | Feb 4, 2014 | 37 |
| -24.24% | Sep 23, 2013 | 32 | Nov 5, 2013 | 15 | Nov 26, 2013 | 47 |
| -23.97% | Apr 11, 2013 | 47 | Jun 17, 2013 | 65 | Sep 18, 2013 | 112 |
Volatility
Volatility Chart
The current Enanta Pharmaceuticals, Inc. volatility is 31.23%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Enanta Pharmaceuticals, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |